Patents by Inventor Junichiro KISHI

Junichiro KISHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compound or salt thereof, natural killer T cell activator, and pharmaceutical composition
    Patent number: 10919926
    Abstract: Problems of the present invention is to provide a novel compound or a salt thereof capable of activating natural killer T cell, a natural killer T cell activating agent containing such a compound or a salt thereof, and a pharmaceutical composition. The compound of the present invention is a compound represented by the following formula (1) or a salt thereof. It is preferable that total carbon number of the number of carbon atoms in the monovalent hydrocarbon group in R1 in the formula (1) excluding a sustitutent and the number of carbon atoms in the divalent hydrocarbon group in X1 is 5 to 50. The natural killer T cell activating agent contains the aforementioned compound or a salt thereof. The pharmaceutical composition contains the aforementioned compound or a pharmacologically acceptable salt thereof.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: February 16, 2021
    Assignees: KEIO UNIVERSITY, REGiMMUNE CORPORATION
    Inventors: Shinsuke Inuki, Natsumi Hirata, Emi Kashiwabara, Junichiro Kishi, Toshihiko Aiba, Yukari Fujimoto
  • COMPOUND OR SALT THEREOF, NATURAL KILLER T CELL ACTIVATOR, AND PHARMACEUTICAL COMPOSITION
    Publication number: 20200207798
    Abstract: The invention provides a compound or a salt thereof capable of activating natural killer T cell, a natural killer T cell activating agent containing such a compound or a salt thereof, and a pharmaceutical composition. The compound of the invention is a compound represented by the following formula (1) or a salt thereof. It is preferable that total carbon number of the number of carbon atoms in the monovalent hydrocarbon group in R1 in the formula (1) excluding a substitutent and the number of carbon atoms in the divalent hydrocarbon group in X1 is 5 to 50. The natural killer T cell activating agent contains the aforementioned compound or a salt thereof. The pharmaceutical composition contains the aforementioned compound or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: March 2, 2017
    Publication date: July 2, 2020
    Applicants: KEIO UNIVERSITY, REGiMMUNE CORPORATION
    Inventors: Shinsuke INUKI, Natsumi HIRATA, Emi KASHIWABARA, Junichiro KISHI, Toshihiko AIBA, Yukari FUJIMOTO